Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants
Clinical trial NCT06506266 · COMPLETED
Trial details
- NCT number
- NCT06506266
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2024-10-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.